MRL/lpr mice can reproduce key clinical pathologies of SLE and more importantly, the hyperactivation and pathogenicity of CD4+ T cell make this mouse model suitable for investigation of senescence-inducing therapy 23-25. This evidence concerns the gene CD4 and systemic lupus erythematosus.